PA Lyme Resources Presents Lyme Impact Series – LDA President, Pat Smith on Lyme Disease: 47 years – Past, Present & Moving Forward, May 17th, 2022 TOPICS COVERED IN VIDEO: […]
Search Results for: lyme test
Katherine Leavey, et al., published, “Lyme borreliosis in pregnancy and associations with parent and offspring health outcomes: An international cross-sectional survey” in Frontiers in Medicine on November 3, 2022. Data regarding the health outcomes of people infected with Lyme disease during pregnancy is limited, as is perinatal transmission to their fetus, and the long-term effects on their children…
Rappahannock News published “Lyme disease is on the rise in Rappahannock. The pandemic obscured by how much.” In the past five years, Rappahannock-Rapidan Health District has seen a rise in cases of Lyme disease, Rocky Mountain spotted fever, Anaplasmosis, and Ehrlichiosis. However, local residents and experts believe case numbers of tick-borne diseases have been vastly under-reported in Virginia.
Arick P.Sabin, et al., published “Clinical evaluation of a Borrelia modified two-tiered testing (MTTT) shows increased early sensitivity for Borrelia burgdorferi but not other endemic Borrelia species in a high incidence region for Lyme disease in Wisconsin” in Diagnostic Microbiology and Infectious Disease on November 9, 2022,* (version of record). Recently, a modified two-tiered testing algorithm (MTTT; ZEUS Scientific) for Borrelia burgdorferi was cleared by the FDA. This led the researchers to assess the algorithm to verify Lyme disease as well as evaluate the results in comparison to those acquired using standard two-tiered testing (STTT).
Daniel J.B. Clarke, et al, published “Gene set predictor for post-treatment Lyme disease” in Cell Reports Medicine on November 15, 2022. The researchers enrolled 152 study participants, each with symptoms of post-treatment Lyme disease (PTLD), to analyze their peripheral blood mononuclear cells (PBMCs) with RNA sequencing (RNA-seq). RNA-seq data from 72 individuals with acute Lyme disease and 44 uninfected controls were incorporated to examine variations in differential gene expression.
The U.S. Department of Health and Human Services (HHS) and the Steven & Alexandra Cohen Foundation (Cohen Foundation) have named ten Phase 1 LymeX Diagnostics Prize winners in the LymeX Innovation Accelerator (LymeX) contest created to advance the progress of diagnostics for Lyme disease. Phase 1 of the multiphase competition called on scientific, technical, and clinical experts to present pioneering methodologies for the detection of active Lyme disease infections in humans with the goal of cultivating the advancement of diagnostics toward review by the Food and Drug Administration.
Shannon Baron, et al., published, “Unresolved Heart Block in Lyme Carditis: A Case Report” in Cureus on September 27, 2022, chronicling the case of a man who was admitted to the emergency department with a day-long history of syncopal episodes.
When the Lyme Disease Association Inc. (LDA) was contacted by a student at Duke Law who wanted to organize a group of students in a Lyme disease pro bono project, I was very excited about the possibilities…Lyme is not just a disease but a political nightmare… this was an opportunity to have some of the brightest and most motivated of our youth tackle this epidemic….The findings from this group of law students can be disseminated and used to empower patients, families, physicians, politicians, and researchers to unravel the secrets surrounding Lyme and provide solutions for Lyme and other tick-borne diseases across the globe.